Tazobax 4 g/ 0,5 g Powder for solution for infusion
PDF Leaflet Revision Date: 22 May 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Treatment of systemic and local bacterial infections.
Dosage (summary)
Adults: 4/0.5 g every 8 hours; Neutropenic patients: every 6 hours.
Special Populations
- Elderly
- Renal impairment
Pregnancy & Breastfeeding
Not established; avoid breastfeeding.
Key Drug Interactions
- Probenecid
- Aminoglycosides
- Oral anticoagulants
Contraindications
- Hypersensitivity to piperacillin or tazobactam
- History of allergic reactions to penicillins
Common side effects
- Diarrhoea
- Rash
- Nausea
- Vomiting
Counselling Points
- Monitor for allergic reactions
- Report severe diarrhoea
- Avoid mixing with other antibiotics
Serious warnings
- Serious hypersensitivity reactions
- Pseudomembranous colitis
- Haemophagocytic lymphohistiocytosis
Important Disclaimer
The Tazobax 4 g/ 0,5 g Powder for solution for infusion professional information leaflet below is the property of Acino Pharma and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
